Octopus and Mercia-backed health tech startup Semble has closed a $15m (£11.6m) Series B funding round as it looks to expand overseas.
London-based Semble has developed a clinical system to replace the outdated technology that many medical providers operate with.
The British Medical Association recently estimated that doctors in England lose more than 13 million working hours a year due to inefficient IT systems.
Semble claims it can solve this with its IT platform that supports the automation of tasks, provides secure patient data exchanges and can be integrated with third-party systems.
“Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient,” said Semble CEO Christoph Lippuner.
“We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”
Lippuner co-founded Semble in 2018 along with Mikael Landau after the pair sold their previous startup, Orogo, to Just Eat.
The firm’s Series B investment was led by Mercia Ventures with additional investment from Octopus Ventures, Smedvig Ventures and Triple Point.
“The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future,” said Alex Gwyther of Mercia Ventures.
With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”
Semble, operating under its original name Heydoc, previously raised $8.3m for its Series A round in September 2021.
The total funding raised by the company is currently $27m.